Cue Health (HLTHQ) Stock Price
Cue Health Price
Over the last 4 years Cue Health grew revenue by 81.1% annually, reaching 70.94 M USD. For Cue Health, the net margin of -526.5% is down versus -312.1% a few years ago.
Cue Health stock price
Details
Stock Price
ⓘHow to Read This Chart
This chart tracks the historical stock price of Cue Health over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.
Total Return vs. Price Return
The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.
Intraday Price Data
When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Cue Health stock reacts to market openings, earnings releases, or breaking news throughout the trading session.
What to Look For
Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Cue Health's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.
| Date | Cue Health Price |
|---|---|
| 8/4/2026 | 0.00 USD |
| 8/3/2026 | 0.00 USD |
| 7/30/2026 | 0.00 USD |
| 7/29/2026 | 0.00 USD |
| 7/28/2026 | 0.00 USD |
| 7/27/2026 | 0.00 USD |
| 7/24/2026 | 0.00 USD |
| 7/23/2026 | 0.00 USD |
| 7/22/2026 | 0.00 USD |
| 7/21/2026 | 0.00 USD |
| 7/20/2026 | 0.00 USD |
| 7/17/2026 | 0.00 USD |
| 7/16/2026 | 0.00 USD |
| 7/15/2026 | 0.00 USD |
| 7/14/2026 | 0.00 USD |
| 7/13/2026 | 0.00 USD |
| 7/10/2026 | 0.00 USD |
| 7/9/2026 | 0.00 USD |
| 7/8/2026 | 0.00 USD |
| 7/7/2026 | 0.00 USD |
| 7/6/2026 | 0.00 USD |
| 7/2/2026 | 0.00 USD |
| 7/1/2026 | 0.00 USD |
| 6/30/2026 | 0.00 USD |
| 6/29/2026 | 0.00 USD |
| 6/26/2026 | 0.00 USD |
| 6/25/2026 | 0.00 USD |
| 6/24/2026 | 0.00 USD |
| 6/23/2026 | 0.00 USD |
| 6/22/2026 | 0.00 USD |
| 6/18/2026 | 0.00 USD |
| 6/17/2026 | 0.00 USD |
| 6/16/2026 | 0.00 USD |
| 6/15/2026 | 0.00 USD |
| 6/12/2026 | 0.00 USD |
| 6/11/2026 | 0.00 USD |
| 6/10/2026 | 0.00 USD |
| 6/9/2026 | 0.00 USD |
| 6/8/2026 | 0.00 USD |
| 6/5/2026 | 0.00 USD |
| 6/4/2026 | 0.00 USD |
| 6/3/2026 | 0.00 USD |
| 6/2/2026 | 0.00 USD |
| 6/1/2026 | 0.00 USD |
| 5/29/2026 | 0.00 USD |
| 5/28/2026 | 0.00 USD |
| 5/27/2026 | 0.00 USD |
| 5/26/2026 | 0.00 USD |
| 5/22/2026 | 0.00 USD |
| 5/21/2026 | 0.00 USD |
| 5/20/2026 | 0.00 USD |
| 5/19/2026 | 0.00 USD |
| 5/18/2026 | 0.00 USD |
| 5/15/2026 | 0.00 USD |
| 5/14/2026 | 0.00 USD |
| 5/13/2026 | 0.00 USD |
| 5/12/2026 | 0.00 USD |
| 5/11/2026 | 0.00 USD |
| 5/7/2026 | 0.00 USD |
| 5/5/2026 | 0.00 USD |
| 4/30/2026 | 0.00 USD |
Cue Health Revenue, EBIT, Net Income
3 Years
5 Years
10 Years
25 Years
Max
Details
Cue Health Income Statement, Balance Sheet, Cash Flow Statement
| REVENUEM USD |
|---|
| REVENUE GROWTH% |
| GROSS MARGIN% |
| GROSS INCOMEM USD |
| EBITM USD |
| EBIT MARGIN% |
| NET INCOMEM USD |
| NET INCOME GROWTH% |
| SHARESM |
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024e | 2025e | 2026e |
|---|---|---|---|---|---|---|---|
| 6.00 | 23.00 | 618.00 | 483.00 | 70.00 | 58.00 | 113.00 | 213.00 |
| – | 283.33 | 2,586.96 | -21.84 | -85.51 | -17.14 | 94.83 | 88.50 |
| 100.00 | 34.78 | 55.18 | 31.68 | -80.00 | -80.00 | -80.00 | -80.00 |
| 6.00 | 8.00 | 341.00 | 153.00 | -56.00 | -46.40 | -90.40 | -170.40 |
| -20.00 | -45.00 | 190.00 | -203.00 | -296.00 | -232.00 | -184.00 | -113.00 |
| -333.33 | -195.65 | 30.74 | -42.03 | -422.86 | -400.00 | -162.83 | -53.05 |
| -20.00 | -47.00 | 86.00 | -194.00 | -373.00 | -179.00 | -106.00 | -33.00 |
| – | 135.00 | -282.98 | -325.58 | 92.27 | -52.01 | -40.78 | -68.87 |
| 143.80 | 143.80 | 146.60 | 148.00 | 152.88 | 152.88 | 152.88 | 152.88 |
Details
Income Statement Key Figures
ⓘRevenue and Revenue Growth
Revenue is the starting point of every income statement — it measures the total sales Cue Health generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.
Gross Margin
Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Cue Health retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Cue Health's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.
EBIT and EBIT Margin
EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.
Net Income and Earnings Per Share (EPS)
Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.
Shares Outstanding
The total number of shares Cue Health has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.
Analyst Estimates
The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Cue Health's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.
Cue Health stock margins
3 Years
5 Years
10 Years
25 Years
Max
Details
Cue Health Stock Revenue, EBIT, Earnings per Share
3 Years
5 Years
10 Years
25 Years
Max
Details
Cue Health business model & stock analysis
Cue Health SWOT Analysis
Strengths
Cue Health Inc possesses several strengths that contribute to its success and competitive advantage in the market. These strengths include:
- Advanced Technology: Cue Health Inc utilizes cutting-edge technology to develop and manufacture innovative healthcare products.
- Strong Intellectual Property: The company holds a significant number of patents and intellectual property rights, providing a solid foundation for its product development.
- Strategic Partnerships: Cue Health Inc has established strategic partnerships with key industry players, enabling access to distribution networks and market penetration.
- Highly Skilled Workforce: The company boasts a team of talented professionals who possess expertise in various fields, enhancing Cue Health Inc's capabilities and output.
Weaknesses
Despite its strengths, Cue Health Inc also faces certain weaknesses that can hinder its growth and performance. These weaknesses include:
- Reliance on Third-Party Manufacturers: Cue Health Inc depends on external manufacturers for the production of its healthcare products, creating potential supply chain vulnerabilities.
- Limited Product Range: The company's product portfolio is currently focused on a specific segment of the healthcare industry, limiting its overall market potential.
- Relatively New to the Market: Cue Health Inc is a relatively new player in the market, lacking the brand recognition and customer loyalty enjoyed by more established competitors.
Opportunities
Cue Health Inc can capitalize on several opportunities in the market to further expand its business and achieve sustainable growth. These opportunities include:
- Increasing Demand for Remote Healthcare Solutions: The COVID-19 pandemic and the growing preference for remote healthcare services present an opportunity for Cue Health Inc to leverage its technology and offer convenient at-home diagnostic solutions.
- International Expansion: Cue Health Inc has the potential to enter new global markets, tapping into the growing demand for advanced healthcare and diagnostic products.
- Diversification of Product Line: The company can explore diversifying its product range to target additional segments within the healthcare industry, expanding revenue streams and market reach.
Threats
Cue Health Inc should be cautious of potential threats that could impact its operations and market position. These threats include:
- Intense Competition: The healthcare industry is highly competitive, with numerous established players and emerging startups vying for market share. Cue Health Inc must stay innovative and continuously improve its products to stay ahead.
- Regulatory Challenges: Stringent regulations and requirements for healthcare products can pose challenges for Cue Health Inc in terms of compliance and time-to-market.
- Economic Uncertainty: Economic fluctuations and downturns can impact customer spending and overall market demand, potentially affecting Cue Health Inc's sales and growth prospects.
Cue Health Eulerpool Fair Value
Details
Fair Value Estimate
ⓘWhat Is Fair Value?
Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.
Earnings-Based Fair Value
Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.
Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021
Revenue-Based Fair Value
Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"
Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021
Dividend-Based Fair Value
Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.
Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021
How to Use This Chart
When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.
Cue Health historical P/E ratio, EBIT multiple, and P/S ratio
Cue Health annual returns
Details
Annual Return
ⓘWhat This Chart Shows
This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.
Price Return
Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.
Dividend Return
Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.
What to Look For
Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.
Cue Health shares outstanding
3 Years
5 Years
10 Years
25 Years
Max
Details
EESG©
Eulerpool ESG Scorecard© for the Cue Health stock
EEnvironment
20
Environment
SSocial
20
Social
GGovernance (Corporate Governance)
4
Governance (Corporate Governance)
The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.
Cue Health shareholder structure
| % | Name |
|---|---|
0.00000% | |
0.00000% |
Cue Health Executives and Management Board
8 members · avg. age 52 · 38 % women
Mr. Christopher Achar (39)
Director and Chief Business Officer
22.40 M USD
Management
Mr. Clint Sever (39)
Chief Executive Officer, Co-Founder
Mr. Randall Pollard (52)
Chief Accounting Officer, Controller, Principal Financial Officer
Board of Directors
Dr. Joshua Ghaim (56)
Independent Director
Ms. Maria Martinez (66)
Independent Director
Ms. Carole Faig (62)
Independent Director
Dr. Sachin Jain (43)
Independent Director
Ms. Joanne Bradford (60)
Independent Director
Frequently asked questions about Cue Health
The business model of Cue Health Inc is centered around the development and commercialization of diagnostic products for professional and consumer use. Cue Health Inc focuses on molecular diagnostics, leveraging biotechnology, software, and engineering to provide rapid and accurate results. By combining portable and easy-to-use platforms with a wide range of applications, Cue Health Inc aims to empower individuals and healthcare professionals with point-of-care testing solutions. With a focus on user-friendly devices and actionable information, Cue Health Inc strives to improve healthcare outcomes and enhance access to timely and accurate diagnostics.
Cue Health Inc is primarily active in the healthcare industry.
The main competitors of Cue Health Inc in the market include reputable companies such as Abbott Laboratories, Becton, Dickinson and Company (BD), and Roche Diagnostics.
Cue Health Inc is a renowned company specializing in healthcare technology solutions. Established in [year], Cue Health Inc has been at the forefront of developing innovative products for diagnostics and disease monitoring. The company's cutting-edge platform combines advanced molecular diagnostics with user-friendly devices, empowering individuals to take control of their health. With a strong emphasis on accuracy, convenience, and accessibility, Cue Health Inc has built a reputation for delivering reliable and timely results. This commitment to innovation has earned the company widespread recognition and numerous accolades in the healthcare industry. Cue Health Inc continues to revolutionize the way healthcare is delivered, providing individuals and healthcare professionals with valuable tools to make informed decisions and improve overall well-being.
Cue Health Inc has achieved several significant milestones. Notably, the company received Emergency Use Authorization from the U.S. FDA for its rapid, portable COVID-19 test. Cue Health Inc also secured a partnership with the U.S. Department of Health and Human Services to produce and distribute COVID-19 tests. Moreover, the company successfully completed a $100 million funding round, allowing for further expansion and development of its innovative technologies. Additionally, Cue Health Inc has received recognition for its advancements in diagnostics, including winning the 2020 Fast Company's Innovation by Design Award.
Cue Health Inc is primarily present in the United States of America (USA).
Cue Health Inc represents a commitment to improving healthcare access and outcomes. The company's corporate philosophy revolves around technological innovation, convenience, and empowering individuals to take control of their health. By developing portable diagnostic devices and digital health solutions, Cue Health aims to democratize healthcare by providing accurate and timely results at the point of care. With a focus on collaborations and partnerships, Cue Health Inc strives to leverage its cutting-edge technology to revolutionize the way healthcare is delivered. This dedication to innovation and accessibility makes Cue Health Inc a leading player in the healthcare industry.
8 analysts currently rate the Cue Health stock: 0 recommend buying, 3 holding and 5 selling. For 2026, analysts expect Cue Health to generate revenue of 213.56 M USD and earnings per share of -0.22 USD.
Converted at the current exchange rate, the Cue Health share trades at 0.00 EUR (0.00 USD).
The Cue Health share (HLTHQ) is listed on 1 stock exchanges, including: NASDAQ (HLTH).
Cue Health Inc is a company specializing in the development of innovative medical devices and services that allow for rapid and accurate diagnosis of infectious diseases and other conditions. The company was founded in 2010 and is headquartered in San Diego, California. Cue Health has multiple business segments, including diagnostics, digital health, consumer health products, clinical trials, and distributors. These business segments offer a wide range of products and services for various markets and customers. One of Cue Health's core areas is the development and manufacturing of diagnostic devices for use in clinical practice and home use. Cue Health's flagship product is the Cue Health Monitoring Test, a handheld device that enables self-testing for a variety of health conditions, including COVID-19, influenza, and Strep-A diseases. The test can provide accurate results within minutes, speeding up decision-making for medical personnel and improving healthcare for patients. Another business segment of Cue Health is digital health. The company develops apps and platforms for remote medical monitoring and surveillance. For example, the company has developed an app that allows users to manage their health data and test results on their mobile devices. The platform also enables remote monitoring by medical professionals, which can improve patient care and treatment. Cue Health also has a consumer health product line that focuses on the needs and health issues of consumers. These products are sold in retail stores and online and include a variety of health and wellness products such as vitamins, supplements, and pain relievers. Another important business segment of Cue Health is supporting clinical trials by providing diagnostic devices and services. By collaborating with medical researchers and companies, Cue Health can play a crucial role in accelerating the development of new drugs and therapies. In addition to its business segments, Cue Health is also a major distributor of medical devices and accessories. The company works with other industry leaders to offer its customers a comprehensive range of health products and services. Overall, Cue Health has a wide range of business segments and products. The company aims to improve people's lives through better healthcare and technology. With its innovative products and services, Cue Health has taken on an important role in improving global healthcare and is expected to continue growing and expanding in the coming years.
The expected revenue of Cue Health is 213.56 M USD. This figure is based on current financial data and reflects the company's business performance.
The expected profit of Cue Health is -33.59 M USD. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Cue Health is currently -0.00. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Cue Health stock.
The price-to-sales ratio (P/S) of Cue Health is currently 0.00. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Cue Health stock.
The Eulerpool Quality Score for Cue Health is 2/10.
The ISIN of Cue Health is US2297901009. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of Cue Health is HLTHQ. The ticker symbol is used to trade Cue Health shares on the stock exchange.
Cue Health paid dividends every year for the past 0 years.
Cue Health is assigned to the 'Health' sector.
The dividends of Cue Health are distributed in USD.
Cue Health stock
Cue Health Peer Group
Cue Health Ticker
Cue Health FIGI
All fundamentals and in-depth analysis of Cue Health
Our stock analysis for Cue Health stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Cue Health. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.